- US Philly Fed data in macro focus (10 forecast vs 23.2 previous)
- Markets await Fed members speeches
- Canadian housing starts expected to show 257k vs 245.8k previously
- US Philly Fed data in macro focus (10 forecast vs 23.2 previous)
- Markets await Fed members speeches
- Canadian housing starts expected to show 257k vs 245.8k previously
Investors are awaiting second-tier U.S. economic data today, which, amid the prolonged government shutdown, will have to “suffice” as indicators of the economic outlook across the Atlantic. The macro calendar is not particularly busy, with attention focused on the October reading of the Philadelphia Fed Manufacturing Index (Philly Fed).
In the UK, data on GDP, construction spending, and services came in somewhat weaker than expected, although industrial production surprised to the upside. During the Asian session, markets also received soft labor market data from Australia, where the unemployment rate rose from 4.2% to 4.5%, although employment growth exceeded expectations.
Macro Calendar
12:15 PM GMT (CA) – Housing Starts (October): 257k forecast vs 245.8k previous
12:30 PM GMT (US) – Philly Fed Index (October): 10 forecast vs 23.2 previous
Central Bank Speakers
1 PM GMT – Fed’s Waller, Miran, and Barr
2 PM GMT – Fed’s Bowman
2:45 PM GMT – BoE’s Mann
2:45 PM GMT – ECB’s Kocher
4 PM GMT – ECB’s Lagarde
5:30 PM GMT – BoC’s Macklem
6:30 PM GMT – BoE’s Greene
Earnings Calendar
- Before U.S. market open: Charles Schwab, Marsh & McLennan, Intuitive Surgical, BNY Mellon, U.S. Bancorp, Travelers
- After market close: CSX Corp, Interactive Brokers
Multiply Group to Form Dh120B Investment Giant via Merger with 2PointZero and Ghitha Holding
BREAKING: Eurozone trade balance mixed 💶
BREAKING: UK manufacturing data slightly stronger than expected; GDP lags slightly
Morning wrap (16.10.2025)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
